Back to search
FDAFDA · Food and drugs·Recall number Z-1530-2014

Alfa Wassermann Diagnostic Technologies, LLC. ACE AST Reagent. Product Usage: For quantitative determination of AST in serum and lithium heparin plasma using ACE®, ACE Alera® and ACE Axcel Clinical Chemistry Systems. This test is intended for use in clinical laboratories and physician office laboratories.

Published May 7, 2014 · Recall initiated: March 5, 2014

Summary

FDA records medical device Class II recall Z-1530-2014, published May 7, 2014 and initiated March 5, 2014. Recalling firm: Alfa Wassermann, Inc.; Status: Terminated; Reported quantity: SA1047 lot F3609: 146; RX1047 lot F3610: 53; Lot: ACE® AST Reagent Product reorder numbers SA1047 (Lot F3609) and RX1047 (Lot F3610). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Extremely low absorbance readings.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Alfa Wassermann, Inc.
Distributor
US Nationwide Distribution
Lot
ACE® AST Reagent Product reorder numbers SA1047 (Lot F3609) and RX1047 (Lot F3610)
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Alfa Wassermann Diagnostic Technologies, LLC. ACE AST Reagent. Product Usage: For quantitative determination of AST in serum and lithium heparin plasma using ACE®, ACE Alera® and ACE Axcel Clinical Chemistry Systems. This test is intended for use in clinical laboratories and physician office laboratories. recalled?

Yes. FDA published recall Z-1530-2014 on May 7, 2014. Reported hazard: Extremely low absorbance readings.

What should I do if I have this product?

Voluntary: Firm initiated · Letter